Abstract
Acute kidney injury AKI (acute kidney injury) is currently considered a common clinical problem with high incidence in hospitalized patients. One of five hospitalized patients will develop some degree of acute renal impairment.
This fact, together with the negative impact of AKI on the short-term and long-term prognosis of patients as well as renal function and the great economic demands for AKI treatment, require maximum preventive measures to prevent the development of AKI, reduce its progression, and allow restoration of impaired renal function as quickly as possible. Several new biomarkers are currently being studied that detect the development of renal impairment before an elevated creatinine level occurs.
Recent data also clearly state that patients who have undergone AKI may not have full renal function improvement and therefore adequate follow-up of these patients is required.